Impact of Ontario's Generic Drug Pricing Reforms
Author Information
Author(s): Michael R. Law, Alison Morgan, Steven G. Morgan
Primary Institution: The University of British Columbia
Hypothesis
What is the impact of Ontario's generic drug pricing reforms on overall expenditures?
Conclusion
Ontario's pricing reforms significantly reduced generic drug expenditures, and similar reforms in other provinces could lead to substantial savings.
Supporting Evidence
- Generic drug expenditures in Ontario dropped by $181 to $194 million after the pricing reforms.
- If other provinces matched Ontario's prices, they could save approximately $445 million over six months.
- The total annual savings across Canada could reach at least $1.28 billion.
Takeaway
Ontario changed how much it pays for generic drugs, and this saved a lot of money. If other places did the same, they could save even more.
Methodology
The study analyzed quarterly prescription data to estimate expenditure reductions due to the pricing reforms.
Potential Biases
Potential bias due to reliance on existing stock prices and lack of data on private plan dispensing fees.
Limitations
The analysis assumes other provinces would adopt Ontario's pricing policies, and it does not account for new generics entering the market.
Participant Demographics
The study focused on generic drug expenditures in Ontario and projected impacts on other Canadian provinces.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website